Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock, Common [Member]
Antidilutive Securities [Axis]
Share-Based Payment Arrangement, Option [Member]
Warrant [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Cash Securities Purchase Agreements [Member]
Pre-funded Warrants [Member]
Sale of Stock [Axis]
Cryptocurrency Offering [Member]
Cash Offering and Cryptocurrency Offering [Member]
Cash Securities Purchase Agreements And Crytocurrency Securities Purchase Agreements [Member]
Strategic Advisor Warrants [Member]
2025 ATM Agreement [Member]
Statistical Measurement [Axis]
Maximum [Member]
March 2026 ATM Agreement [Member]
Plan Name [Axis]
2017 Stock Incentive Plan [Member]
2019 Stock Incentive Plan [Member]
2023 Omnibus Equity Incentive Plan [Member]
Class of Stock [Axis]
Award Type [Axis]
Restricted Stock Units (RSUs) [Member]
Statements Of Income Location Balance [Axis]
Research and Development Expenses [Member]
General and Administrative Expenses [Member]
Warrants One [Member]
Warrants Two [Member]
Warrants Three [Member]
Warrants Four [Member]
Warrants Five [Member]
Warrants Six [Member]
Warrants Seven [Member]
Warrants Eight [Member]
Warrants Nine [Member]
Warrants Ten [Member]
Warrants Eleven [Member]
Warrants Twelve [Member]
Warrants Thirteen [Member]
Warrants Fourteen [Member]
Warrants Fifteen [Member]
Warrants Sixteen [Member]
Warrants Seventeen [Member]
Warrants Eighteen [Member]
Warrants Nineteen [Member]
Warrants Twenty [Member]
Warrants Twenty One [Member]
Warrants Twenty Two [Member]
Warrants Twenty Three [Member]
Warrants Twenty Four [Member]
Minotaur Agreement [Member]
ABSI [Member]
ABSI [Member]
Intract Patent License Agreement (Member)
Avior Patent License Agreement [Member]
Enkefalos License Agreement [Member]
Related and Nonrelated Parties [Axis]
Related Party [Member]
Investment, Name [Axis]
President Street Global [Member]
Segments [Axis]
Digital Asset Treasury [Member]
Clinical Stage Bio Technology [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Information, Former Legal or Registered Name
Statement of Financial Position [Abstract]
ASSETS
Current assets
Cash
Prepaid expenses and other current assets
Total current assets
Digital assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable
Accrued expenses
Total current liabilities
Deferred tax liability
Total liabilities
Commitments and contingencies (see Note 7)
Stockholders’ equity
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2026 and December 31, 2025
Common stock, $0.0001 par value, 1,000,000,000 shares authorized as of March 31, 2026 and December 31 2025, 56,656,517 shares and 37,112,466 shares issued and 56,656,271 shares and 37,112,220 shares outstanding as of March 31, 2026 and December 31 2025, respectively
Additional paid-in capital
Accumulated deficit
Treasury stock, at cost, 246 shares held in treasury as of March 31, 2026 and December 31, 2025
Total stockholders’ equity
Total liabilities and stockholders’ equity
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Treasury stock, common shares
Income Statement [Abstract]
Operating expenses
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense)
Interest expense
Interest income
Unrealized loss from digital assets holdings
Total other income (expense), net
Total loss before income taxes
Provision (benefit) for income taxes
Net loss
Net loss per share:
Basic
Diluted
Weighted average number of common shares outstanding:
Basic
Diluted
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Treasury stock, shares
Cashless exercise of pre-funded warrants
Cashless exercise of pre-funded warrants, shares
Stock issued pursuant to bonus liability
Stock issuance pursuant to bonus liability, shares
Restricted stock unit issuance pursuant to service agreement
Restricted stock unit issuance pursuant to service agreement, shares
Net loss
Stock based compensation
Registered direct public offerings, net of issuance costs of $2,195,772
Registered direct public offerings, net of issuance costs of $2,195,772, shares
At-the-market offerings, net of issuance costs
At-the-market offering, net of issuance costs, shares
Cashless exercise of common warrants
Cashless exercise of common warrants, shares
Exercise of common warrants
Exercise of common warrants, shares
Issuance costs
Balance
Balance, shares
Treasury stock, shares
Statement of Stockholders' Equity [Abstract]
Public offerings, stock issuance costs
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Unrealized loss from digital assets holdings
Deferred tax benefit
Stock based compensation
Increase in operating assets:
Prepaid expenses and other current assets
Increase in operating liabilities:
Accounts payable
Accrued expenses
Net cash used in operating activities
Cash flows from investing activities:
Purchase of digital assets
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock upon registered direct public equity offerings
Proceeds from issuance of common stock upon at-the-market offerings
Proceeds from exercise of common stock warrants
Payment of deferred offering costs and other issuance costs
Proceeds from insurance premium financing liability
Repayment of insurance premium financing liability
Repayments of note payable
Net cash provided by financing activities
Net increase (decrease) in cash
Cash, beginning of period
Cash, end of period
Cash paid for interest expense
Supplemental disclosure of non-cash financing activities:
Issuance of note payable for settlement of previously incurred professional fees
Issuance of options to settle liability
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Accounting Policies [Abstract]
Description of Business
Summary of Significant Accounting Policies
Intangible Asset, Goodwill and Other [Abstract]
Digital Assets
Equity [Abstract]
Common Stock
Share-Based Payment Arrangement [Abstract]
Stock Based Compensation
Income Tax Disclosure [Abstract]
Income Taxes
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Related Party Transactions [Abstract]
Related Party Transactions
Segment Reporting [Abstract]
Segment Reporting
Subsequent Events [Abstract]
Subsequent Events
Basis of Presentation
Principles of Consolidation
Use of Estimates
Segment Reporting
Concentration of Credit Risk
Cash and Cash Equivalents
Research and Development
Stock-Based Compensation
Fair Value Measurements
Income Taxes
Patent Costs
Net Loss per Share
Recent Accounting Pronouncements
Schedule of Potentially Dilutive Equity Shares not Included in Computation of EPS
Schedule of Digital Assets Held
Schedule of Reconciliation of Digital Assets
Schedule of Stock Option Activity
Schedule of Options Weighted Average Assumptions
Schedule of Stock-Based Compensation Expense
Schedule of Warrants
Schedule of Effective Income Tax Rate and Income Tax Provision (benefit)
Schedule of Segment Financial Performance
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities
FDIC insured amount
Units held
Cost basis
Fair value
Fair value, December 31, 2025 balance
Additions from purchases
Unrealized losses
Fair value, March 31, 2026 balance
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common Stock, Shares Authorized
Number of shares sold
Warrants to purchase common stock
Offering price
Proceeds from the common stock offering
Proceeds from pre-funded warrants
Proceeds from sale of stock
Offering cost
Warrants exercise price per share
Number of shares sold value
Shares of common stock
Shares issued price
Shares underlying option, outstanding, beginning balance
Weighted average exercise price, outstanding, beginning balance
Weighted average contractual terms, outstanding
Shares underlying option, Forfeited
Weighted average exercise price, Forfeited
Shares underlying option, outstanding, ending balance
Weighted average exercise price, outstanding, ending balance
Shares underlying option, exercisable
Weighted average exercise price, exercisable
Weighted average contractual terms, exercisable
Shares underlying option, vested and expected to vest
Weighted average exercise price, vested and expected to vest
Weighted average contractual terms, vested and expected to vest
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected volatility
Risk-free interest rate
Expected dividend yield
Expected life of options in years
Estimated fair value of options granted
StatementsOfIncomeLocationBalanceAxis [Axis]
Total stock-based compensation
ClassOfWarrantStockTable [Table]
Warrants, Issuance Date
Warrants, Initial Exercise Date
Warrants, Expiration Date
Warrants, Exercise Price
Warrants, Issued
Warrants, Exercised
Warrants, Outstanding
Number of shares authorized for issuance
Options granted in period
Exercise price of option
Number of shares available for forfeited
Number of options, outstanding
Stock option, exercised
Weighted average exercise prices
Weighted average contractual term
Number of shares authorized for issuance
Weighted average grant date fair value of stock options granted
Weighted average fair value of stock options vested
Unrecognized sharebased compensation remaining to be expensed
Stock compensation expense
Warrants per share
Restricted stock units, description
Stock compensation expense
Total fair value of RSUs
Nonvested number of shares
Number of shares issued
Income tax provision (benefit)
Effective income tax
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Upfront payment
Future payment upon meeting milestone
License fees
Common stock issued
Value of common stock issued
Net proceeds from offering
ABSI shares issued, shares
Payments for research and development
Milestone fees
Payment of milestone amount
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Investment ownership percentage
Affilate related party
Affiliate expense
Segment Reporting [Table]
Segment Reporting [Line Items]
Total assets
Loss from operations
Other income (expense) ()
Unrealized loss on digital assets holdings
Consolidated total loss before income taxes
Number of reportable segments
Subsequent Event [Table]
Subsequent Event [Line Items]
Commissions fees
2017 Stock Incentive Plan [Member]
2019 Stock Incentive Plan [Member]
2023 Omnibus Equity Incentive Plan [Member]
Weighted average remaining contractual term for option awards outstanding granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Share based compensation arrangement by share based payment award options outstanding exercised weighted average remaining contractual term.
Sharebased compensation arrangement by sharebased payment award options outstanding forfeited weighted average remaining contractual term.
Cashless exercise of prefunded warrants net of cancellation.
Cashless exercise of pre-funded warrants, net of cancellation, shares.
Strategic Advisor Warrants [Member]
Stock issued during period value registered direct public offerings net of issuance costs.
Stock issued during period shares registered direct public offerings net of issuance costs.
Stock issued during period value cashless exercise of common warrants.
Stock issued during period shares cashless exercise of common warrants.
Class of warrant or righst date from which warrants or rights issuance.
Warrants One [Member]
Class of warrant or right issued.
Stock issued during period value bonus liability.
Class of warrant exercised.
Stock issued during period shares bonus liability.
Warrants Two [Member]
Stock issued during period value exercise of common warrants.
Stock issued during period shares exercise of common warrants.
Warrants Three [Member]
Warrants Four [Member]
Warrants Five [Member]
Warrants Six [Member]
Warrants Seven [Member]
Warrants Eight [Member]
Warrants Nine [Member]
Warrants Ten [Member]
Proceeds from issuance of common stock upon registered direct public offerings.
Proceeds from issuance of common stock upon at the market offerings.
Proceeds from insurance premium financing liability.
Repayment of insurance premium financing liability.
Issuance of options to settle liability.
Warrants Eleven [Member]
Warrants Twelve [Member]
Warrants Thirteen [Member]
Warrants Fourteen [Member]
Warrants Fifteen [Member]
Warrants Sixteen [Member]
Warrants Seventeen [Member]
Digital Assets [Policy Text Block]
Warrants Eighteen [Member]
Warrants Nineteen [Member]
Patent Costs [Policy Text Block]
Warrants Twenty [Member]
Warrants Twenty One [Member]
Warrants Twenty Two [Member]
Warrants Twenty Three [Member]
Warrants, June 2025 PIPE [Member]
Warrants Twenty Four [Member]
Total estimated fair value of RSUs.
Cash Securities Purchase Agreements [Member]
Pre-funded Warrants [Member]
Cryptocurrency Offering [Member]
Upfront payment.
Furture milestone payment.
License fees.
Minotaur Agreement [Member]
ABSI [Member]
ABSI [Member]
Milestone payment.
Intract Patent License Agreement (Member)
Milestone fees.
Avior Patent License Agreement [Member]
Enkefalos License Agreement [Member]
Restated Employment Agreement [Member]
Target bonus percentage of salary.
CEO Settlement Agreement [Member]
Financing in debt equity.
Chairman Employment Agreement [Member]
Increase in executive salary.
Cash bonus.
Description of cash bonus.
Mr Wendland [Member]
Sign on bonus (amount has not been paid yet).
Performance cash bonus.
2026 [Member]
Mr Toomey [Member]
Cash Offering and Cryptocurrency Offering [Member]
Cash Securities Purchase Agreements And Crytocurrency Securities Purchase Agreements [Member]
2025 ATM Agreement [Member]
Sales agent commissions.
Investment ownership percentage.
President Street Global [Member]
June 2025 PIPE Offering [Member]
Series A Warrants [Member]
Series B Warrants [Member]
Due to affilated related party.
Placement Agent Warrants [Member]
Cash charitable contribution to related party organization.
Affiliate expenses.
Digital Asset Treasury [Member]
Clinical Stage Bio Technology [Member]
Statements of income location balance axis.
Research and Development Expenses [Member]
General and Administrative Expenses [Member]
March 2026 ATM Agreement [Member]
Warrants, IPO [Member]
Warrants, May 2023 [Member]
Warrants, November 2023 [Member]
Warrants, June 2024 PIPE [Member]
Warrants, December 2024 PIPE [Member]
Placement Agent Warrants, June 2024 PIPE [Member]
Placement Agent Warrants, December 2024 PIPE [Member]
Warrants, July 2025 PIPE [Member]
Placement Agent Warrants, June 2025 PIPE [Member]
Placement Agent Warrants, July 2025 PIPE [Member]
Warrant July 2025 RDO [Member]
Strategic Advisor Warrants, November 2025 Offering [Member]
ABSI [Member] [Default Label]
Assets, Current
Liabilities, Current
Liabilities
Treasury Stock, Value
Equity, Attributable to Parent
Liabilities and Equity
Operating Expenses
Interest Expense, Nonoperating
Nonoperating Income (Expense)
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Diluted
Shares, Outstanding
Share-Based Payment Arrangement, Noncash Expense
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Payable, Trade
Increase (Decrease) in Accrued Liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payment for Acquisition, Crypto Asset
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Payments of Financing Costs
RepaymentOfInsurancePremiumFinancingLiability
Repayments of Notes Payable
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Segment Reporting, Policy [Policy Text Block]
Income Tax, Policy [Policy Text Block]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized